Why the study?
Does statin therapy reduce the progression of carotid intimal-medial thickness?
Population
11 trials pooling 3,806 patients, mean age 58.7 years, 67.2% males and 22.8% females.
Comparison
Statin therapy for a mean treatment duration of… vs Control group / placebo arm
Design
Meta-analysis
Follow-up
mean 25.6 months
Authors
Loading...
Reinforces statin use in subclinical atherosclerosis; confirms consistent CIMT benefit across randomized trials.
Does statin therapy reduce the progression of carotid intimal-medial thickness?
Statin therapy significantly slows the progression of carotid intimal-medial thickness, demonstrating measurable benefits at the subclinical stage of atherosclerosis.
Bedi et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: